Skip to content

Oral Nutritional Supplementation in Children

Oral Nutritional Supplementation in Children With Picky Eating Behaviors

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02125123
Enrollment
26
Registered
2014-04-29
Start date
2014-04-30
Completion date
2015-07-31
Last updated
2015-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children

Brief summary

This study will investigate the effect of an oral nutritional supplement (ONS) along with dietary counseling on improving the dietary intake among children with picky eating behaviors.

Interventions

OTHERNutritional Supplement and Counseling

Ready-to-feed nutritional supplement and dietary counseling

OTHERCounseling

Dietary counseling

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
36 Months to 109 Months
Healthy volunteers
Yes

Inclusion criteria

1. ≥ 36 months and \< 109 months of age. 2. Healthy and not suffering from any physical disability. 3. Height-for-age and BMI-for-age between the 5th and the 95th percentile; weight-for-age between the 5th and the 85th percentile. 4. Capable of oral feeding. 5. Has a mean score of greater than 3.0 on the fussiness category in the Children's Eating Behaviour Questionnaire and also consumes on average less than the daily recommendations for at least 3 of 5 food groups (Dietary Guidelines for America, 2010). 6. Willing to abstain from consuming non-study nutritional supplements during the study intervention period.

Exclusion criteria

1. History of an acute or chronic condition that may affect feeding habits or nutritional status. 2. Taking any medications or nutritional supplements on a daily basis for more than 2 weeks during the past month that may profoundly affect feeding habits or nutritional status. 3. Clinically significant nutritional deficiency requiring specific treatment with any other nutritional supplement. 4. Any acute/chronic condition requiring medical treatment which may include hospitalization. 5. Allergy or intolerance to any ingredient in the study product. 6. Gastrointestinal infection, acute constipation or acute diarrhea. 7. Hepatitis B or C, or HIV, or malignancy. 8. Congenital cardiac defects. 9. Dysphagia, aspiration risk or difficulty in swallowing due to acquired/congenital abnormalities. 10. Parent(s)/LG of the subject has any clinically significant medical disease or physical/psychological condition that may interfere with protocol adherence or ability of the parent(s)/LG to give informed consent.

Design outcomes

Primary

MeasureTime frame
Vitamin D IntakeChange from Baseline to Week 4

Secondary

MeasureTime frameDescription
Macronutrient IntakeChange from Baseline to Week 424-hour dietary recall interview
Micronutrient IntakeChange from Baseline to Week 424-hour dietary recall interview

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026